215656-99-8

Basic information

• Product Name: 4-(tert-Butyldimethylsilyl)oxy-2-nitroaniline
• Synonyms: 4-(tert-Butyldimethylsilyl)oxy-2-nitroaniline;4-[[(1,1-DiMethylethyl)diMethylsilyl]oxy]-2-nitro-benzenaMine
• CAS NO: 215656-99-8
• Molecular Formula: C₁₂H₂₀N₂O₃Si
• Molecular Weight: 268.3843
• Product Categories: Aromatics;Miscellaneous Reagents;Aromatics, Miscellaneous Reagents
• Mol File: 215656-99-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 353.1±27.0 °C(Predicted)
• Appearance: /
• Density: 1.091±0.06 g/cm3(Predicted)
• Solubility: Dichloromethane, Methanol
• PKA: 0.95±0.10(Predicted)
• CAS DataBase Reference: 4-(tert-Butyldimethylsilyl)oxy-2-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(tert-Butyldimethylsilyl)oxy-2-nitroaniline(215656-99-8)
• EPA Substance Registry System: 4-(tert-Butyldimethylsilyl)oxy-2-nitroaniline(215656-99-8)

Safety Data

• Hazardous Substances Data: 215656-99-8(Hazardous Substances Data)

Usage

Chemical Properties

Brown Solid

Uses

Intermediate in the production of antithrombotic agents.

Upstream product

• 610-81-1 4-hydroxy-2-nitroaniline 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 219518-89-5 N-(3-cyanobenzoyl)-2-nitro-4-(tert-butyldimethylsilyloxy)aniline 
• 219518-90-8 N₁-(3-cyanobenzoyl)-4-(dimethyl-t-butylsiloxy)-1,2-benzenediamine 
• 219518-92-0 N¹-(3-cyanobenzoyl)-N²-(4-isopropylbenzoyl)-4-hydroxy-1,2-benzenediamine 
• 219518-93-1 N¹-(3-(amino(hydroxyimino)methyl)benzoyl)-N²-(4-iso-propylbenzoyl)-4-hydroxy-1,2-benzenediamine 
• 219518-91-9 N¹-(3-cyanobenzoyl)-N²-(4-isopropylbenzoyl)-4-(tert-butyldimethylsilyloxy)-1,2-benzenediamine 
• 219518-98-6 N¹-(3-cyanobenzoyl)-N²-(4-iso-propylbenzoyl)-4-ethoxycarbonylmethoxy-1,2-benzenediamine 
• 219518-99-7 N¹-(3-(amino(hydroxyimino)methyl)benzoyl)-N²-(4-iso-propylbenzoyl)-4-ethoxycarbonylmethoxy-1,2-benzenediamine 
• 219518-95-3 N¹-(3-cyanobenzoyl)-N²-(4-isopropylbenzoyl)-4-benzyloxycarbonylmethoxy-1,2-benzenediamine 
• 219518-96-4 N¹-(3-(amino(hydroxyimino)methyl)benzoyl)-N²-(4-isopropylbenzoyl)-4-benzyloxycarbonylmethoxy-1,2-benzenediamine 
• 219519-20-7 N-(t-butoxycarbonyl)-2-nitro-4-(dimethyl-t-butylsiloxy)aniline 
• 201811-20-3 tert-butyl N-(4-hydroxy-2-nitrophenyl)carbamate 
• 726206-94-6 C₁₄H₂₀N₂O₅ 
• 726207-19-8 C₂₄H₂₀ClN₃O₆S 
• 1345687-91-3 4-{ [tert-butyl(dimethyl)silyl]oxy}-N¹-{4-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}benzene-1,2-diamine 

Relevant articles and documents

Synthesis and bioluminescence of electronically modified and rotationally restricted colour-shifting infraluciferin analogues

Synthetic nIR emitting luciferins can enable clearer bioluminescent imaging in blood and tissue. A limiting factor for all synthetic luciferins is their reduced light output with respect to D-luciferin. In this work we explore a design feature of whether

Condensed tricyclic compounds as RAF kinase inhibitors

The invention provides certain condensed tricyclic compounds as well as salt, compositions and application methods thereof.

Membrane-permeable Mn(III) complexes for molecular magnetic resonance imaging of intracellular targets

Intracellular compartments make up roughly two-thirds of the body, but delivery of molecular imaging probes to these spaces can be challenging. This situation is particularly true for probes designed for detection by magnetic resonance imaging (MRI), a hi